Top-Rated Stocks NASDAQ:NTRA Natera - NTRA News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $56.65 +0.95 (+1.71%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$54.32▼$56.7250-Day Range$39.72▼$58.2952-Week Range$27.35▼$59.75Volume917,175 shsAverage Volume1.44 million shsMarket Capitalization$6.42 billionP/E RatioN/ADividend YieldN/APrice Target$79.27 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address NTRA Media Mentions By Week NTRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTRA News Sentiment▼0.000.52▲Average Medical News Sentiment NTRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTRA Articles This Week▼34▲NTRA Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMichael Burkes Brophy Sells 651 Shares of Natera, Inc. (NASDAQ:NTRA) Stockmarketbeat.com - March 24 at 10:25 PMAssenagon Asset Management S.A. Has $26.69 Million Stake in Natera, Inc. (NASDAQ:NTRA)marketbeat.com - March 22 at 5:28 AMNatera, Inc. (NASDAQ:NTRA) Given Average Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - March 20 at 2:15 AMNew Publication Demonstrates Utility of Natera’s Signatera™ Test in Melanomabusinesswire.com - March 22 at 8:10 AMNatera Announces Commercial Payor Coverage for Signatera™finance.yahoo.com - March 2 at 11:38 AMNatera Appoints Ruth E. Williams-Brinkley to its Board of Directorsfinance.yahoo.com - February 23 at 11:23 AMNatera Announces Fourth Quarter and Fiscal 2022 Earnings Conference Callfinance.yahoo.com - February 21 at 11:15 AMMedicare Extends Coverage of Natera’s Signatera™ MRD Test to Breast Cancerfinance.yahoo.com - February 16 at 8:41 AMNatera's (NASDAQ:NTRA) investors will be pleased with their fantastic 394% return over the last five yearsfinance.yahoo.com - February 4 at 10:17 AMNew Paper Highlights Clinical Utility of Natera's Renasight(TM) Test in the Management of Kidney Diseasewsj.com - February 3 at 8:28 AMNew Paper Highlights Clinical Utility of Natera’s Renasight™ Test in the Management of Kidney Diseasefinance.yahoo.com - February 2 at 10:47 AMNew Signatera™ MRD Data in Gastrointestinal Cancers to be Presented at the ASCO GI Symposium 2023finance.yahoo.com - January 19 at 10:17 AMNatera Announces Publication of Prospective, Multi-Site CIRCULATE Study in Nature Medicine Demonstrating Signatera’s Ability to Predict Chemotherapy Benefit in Colorectal Cancerfinance.yahoo.com - January 17 at 9:32 AMWall Street Analysts Think Natera (NTRA) Could Surge 82.88%: Read This Before Placing a Betfinance.yahoo.com - January 12 at 3:38 PMNatera to Webcast Live Presentation at the 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 3 at 8:13 PMA Natera, Inc. (NASDAQ:NTRA) insider increased their holdings by 13% last yearfinance.yahoo.com - January 3 at 10:12 AMNatera Supports Updated ISHLT Guidelines for the Care of Heart Transplant Patientsfinance.yahoo.com - December 22 at 12:26 AMNatera Announces Publication of Multi-Center Study Validating Signatera's Ability to Predict Recurrence in Esophageal and Gastric Cancersfinance.yahoo.com - December 9 at 8:45 AMNatera to Present New Signatera™ and Empower™ Data at the 2022 Annual San Antonio Breast Cancer Symposiumfinance.yahoo.com - December 7 at 2:14 PMAfter losing 58% in the past year, Natera, Inc. (NASDAQ:NTRA) institutional owners must be relieved by the recent gainfinance.yahoo.com - December 7 at 2:14 PMNatera Announces Publication of Clinical Experience Study with 18,984 Twin Pregnancies Supporting Excellent Performance of Panorama™ NIPTfinance.yahoo.com - December 6 at 6:42 AMNatera to Participate in the Piper Sandler 34th Annual Healthcare Conferencefinance.yahoo.com - November 23 at 10:55 AMNew Published Study Further Demonstrates the Ability of Natera's mPCR Technology to Monitor Immunotherapy Response in Metastatic Uveal Melanoma Patientsfinance.yahoo.com - November 21 at 12:20 PMNatera Third Quarter 2022 Earnings: Beats Expectationsfinance.yahoo.com - November 10 at 11:00 PMNatera Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 8 at 6:08 PMNatera (NTRA) Shares Outperformed in the Third Quarter on Positive Business Updatesfinance.yahoo.com - November 4 at 11:15 AMNatera Awarded National MRD Testing Contract by the U.S. Department of Veterans Affairsfinance.yahoo.com - November 2 at 6:11 PMNatera to Report its Third Quarter 2022 Results on November 8thfinance.yahoo.com - November 1 at 2:31 PMNatera to Participate in Credit Suisse 31st Annual Healthcare Conferencefinance.yahoo.com - November 1 at 2:31 PMNatera, Inc. (NTRA)finance.yahoo.com - October 26 at 2:34 PMNTRA December 16th Options Begin Trading - Nasdaqnasdaq.com - October 17 at 4:39 PMNaturally Splendid says Denny's renews agreement to provide Plantein plant-based Nuggets and Crumbed Tenders at all its restaurants across Canada - Proactive Investors USAproactiveinvestors.com - October 12 at 10:45 AMNatera: Cracks In The Bearish Tradeseekingalpha.com - October 11 at 2:38 PMQuest Diagnostics agrees to settlement of DNA-test patent dispute - Reutersreuters.com - October 10 at 3:46 PMNew Publication Validates Performance of Natera's Signatera™ MRD Test in Ovarian Cancerfinance.yahoo.com - October 6 at 9:07 AMNatera gains on publication of data on transplant rejection assessment test (NASDAQ:NTRA) - Seeking Alphaseekingalpha.com - October 4 at 9:16 PMNatera (NTRA) Reports Study Showing Prospera Kidney dd-cfDNA Test Outperforms DSA in Predicting Antibody Mediated Rejection - StreetInsider.comstreetinsider.com - October 4 at 4:16 PMNatera Announces 2025 ESG Goals with Publication of 2021 Reportfinance.yahoo.com - September 29 at 1:03 PMNatera (NASDAQ:NTRA) – Natera Presents New Colorectal And Breast Cancer Data From The CIRCULATE-Japan Stu - Benzingabenzinga.com - September 12 at 3:43 PMNatera Presents New Colorectal and Breast Cancer Data at ESMO 2022, Highlighting Signatera's Ability to Inform Treatment Decisions in the Adjuvant and Neoadjuvant Settingsfinance.yahoo.com - September 12 at 10:43 AMNTRA.O - Natera Inc | Stock Price & Latest News | Reutersreuters.com - September 8 at 12:00 PMNatera Inc (NTRA) – Natera to Participate in Upcoming Investor Conferences - Benzingabenzinga.com - September 6 at 6:04 PMIs Natera (NASDAQ:NTRA) Using Too Much Debt? - Nasdaqnasdaq.com - September 5 at 6:14 PMHereditary Testing Market (Size, Volume, Share & Trends) — Report Comparison by Rating, ToC, Page Count, and Price only at Douglas Insights - Yahoo Financefinance.yahoo.com - September 1 at 9:24 PMNTRA.OQ - Natera Inc | Stock Price & Latest News | Reutersreuters.com - August 28 at 10:33 PMFirst Week of April 2023 Options Trading For Natera - Nasdaqnasdaq.com - August 25 at 10:49 PMBenzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 - Benzingabenzinga.com - August 25 at 5:48 PMNatera Earns Great Place to Work Certification™ for Second Consecutive Yearfinance.yahoo.com - August 25 at 12:48 PMThis Unpopular Move Could Save Invitae - TheStreetthestreet.com - August 19 at 6:21 PMNatera Announces Enrollment Completion for RenaCARE Studyfinance.yahoo.com - August 11 at 4:02 PMNatera Announces Q-Sub Filing with FDA for its Panorama® NIPTfinance.yahoo.com - August 10 at 8:41 PMUnited Kingdom Non-Invasive Prenatal Testing Market Report 2022-2028 Featuring Natera, NIPD Genetics, You - Benzingabenzinga.com - August 10 at 3:40 PMNatera, Inc. (NTRA) CEO Steve Chapman on Q2 2022 Results - Earnings Call Transcript - Seeking Alphaseekingalpha.com - August 6 at 10:14 PM Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:NTRA) was last updated on 3/24/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.